A lawyer for the U.S. Chamber of Commerce on Friday urged a federal judge to block President Joe Biden's administration from implementing a new program that would let Medicare negotiate prices with ...

The Chamber of Commerce urged a federal judge on Friday to stop the new Medicare drug price negotiation program before Oct. 1 ...

Drug companies challenging the law in court could still have several chances to stop the program before next year's election.

One Republican mocked Medicare drug price negotiation as “godfather mafia-style” policy, saying it lets the government steal ...

Boehringer Ingelheim is the latest large drugmaker to challenge the U.S. government over Medicare’s new power to negotiate prices of select top-selling medicines, filing a 62-page lawsuit Friday ...

“Congress knew that withdrawing all products from federal healthcare programs would be economic suicide—not a ‘real option.’” – U.S. Chamber motion for preliminary injunction On August ...

Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...

The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking a swipe at the powerful pharmaceutical industry. It marks a major ...

The legal challenges to President Biden's drug price negotiation law could be on a collision course with the 2024 election. Why it matters: Should the Medicare negotiation program survive its first ...

Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...

A major turning point in the battle to control ever-rising drug prices The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking ...